Pharmacological activation of FOXO3 suppresses triple-negative breast cancer <i>in vitro</i> and <i>in vivo</i>

See‐Hyoung Park(Hongik University), Mickey C.‐T. Hu(Gynecologic Oncology Group)
Oncotarget
June 7, 2016
Cited by 54


Related Papers